Pages

Wednesday, June 25, 2014

Lonza says stem cell reprogramming makes for better preclinical models

Lonza has launched a new stem cell reprogramming and maintenance system that has already been used to support US NIH and pharmaceutical company preclinical drug development projects.

http://ift.tt/1lUPoj7?

No comments:

Post a Comment